fELLOW

Lance is a Director with the central Strategy & Innovation division of Siemens Healthcare. Dr. Ladic’s primary responsibility is scouting, evaluating and leading collaborative innovation projects related to emerging technologies. Dr. Ladic participates in several external activities, such as serving on University Industrial Advisory Boards for Bioengineering, ISO TC 229 (Nanomedicine) and organizing/chairing sessions for industry conferences related to emerging lab and diagnostic technologies. Over his 13+ years with Siemens, he has held a variety of strategy related roles in Lab Diagnostics and Corporate Technology. Prior to joining Siemens, Lance worked for GE Healthcare in both medical imaging/related IT systems as well as e-Business areas. His interests and expertise are diverse and include in vitro diagnostics, in vivo imaging, advanced informatics/IT and mobile health technologies.

Dr. Ladic has a B.Sc. in genetics/cell biology and an interdisciplinary Ph.D. in neurophysiology and computer science, both from the University of British Columbia in Vancouver, Canada.